{"schema_version":"secwatch.filing_event.v1","accession":"0001013762-23-000463","form_type":"8-K","ticker":"BJDX","cik":"0001704287","company_name":"Bluejay Diagnostics, Inc.","filed_at":"2023-10-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.109067+00:00","generated_at":"2026-06-10T06:24:39.740719+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bluejay Diagnostics CFO Kenneth Fisher departs; Frances Scally named interim CFO","bullets":["Kenneth R. Fisher ceased as CFO on September 26, 2023; may receive severance per employment agreement.","Frances Scally, age 56, appointed interim CFO, principal financial officer and principal accounting officer.","Scally is an employee of DLA LLC; services provided under a scope of work agreement on an hourly basis.","Scott Levy of DLA also appointed as a special advisor to the CEO."],"urls":{"canonical":"https://secwatch.observer/filing/0001013762-23-000463","json":"https://secwatch.observer/filing/0001013762-23-000463.json","markdown":"https://secwatch.observer/filing/0001013762-23-000463.md","text":"https://secwatch.observer/filing/0001013762-23-000463.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1704287/000101376223000463/0001013762-23-000463-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1704287/000101376223000463/ea186147-8k_bluejay.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T06:24:39.740719+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2d4befd397","claim":"Kenneth R. Fisher departed as Chief Financial Officer at Bluejay Diagnostics, Inc..","evidence_excerpt":"On September 26, 2023, Bluejay Diagnostics, Inc. (the “Company”) and Kenneth R. Fisher agreed that Mr. Fisher would depart the Company as an employee and cease serving as its Chief Financial Officer (“CFO”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1704287/000101376223000463/0001013762-23-000463-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"63c098d9da","claim":"Scott Levy was appointed as special advisor to the CEO at Bluejay Diagnostics, Inc..","evidence_excerpt":"Under the these agreements, Scott Levy will complement Ms. Scally as a special advisor to the Company’s CEO.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1704287/000101376223000463/0001013762-23-000463-index.htm","confidence":0.8,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"special advisor to the CEO"}],"fact_type":"executive_change"},{"claim_id":"f78e2934ff","claim":"Frances Scally was appointed as Chief Financial Officer at Bluejay Diagnostics, Inc..","evidence_excerpt":"On September 26, 2023, the Board of Directors (the “Board”) of the Company appointed Frances Scally, age 56, as interim CFO of the Company and designated her as the Company’s principal financial officer and principal accounting officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1704287/000101376223000463/0001013762-23-000463-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}